Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes
Launched by UNIVERSITY OF ALBERTA · May 29, 2025
Trial Information
Current as of September 10, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how helpful online educational resources—called psychodermatologic educational modules—can be for people with atopic dermatitis (AD), which is a type of eczema. The aim is to see if these resources can improve both the severity of the skin condition and the overall quality of life for patients. The study will involve participants who are at least 4 years old, can speak English well enough to understand the material, and have reliable internet access. Children can participate if their parents or guardians give consent.
If you join this trial, you’ll get access to these educational modules that will help you learn how to manage both the emotional and physical challenges of living with atopic dermatitis. The trial is not yet recruiting participants, but it aims to provide valuable information that could lead to better resources and support for individuals dealing with this skin condition in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. New diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.
- • 2. Reliable internet access to be able to access the e-modules.
- • 3. Able to speak English at a level required to understand the content of this study.
- • 4. Child participants will be included in this study contingent on the consent of their guardian/caregiver(s).
- • 5. Age range of eligible participants: Age 4 years and older.
- Exclusion Criteria:
- • 1. Does not have a new diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.
- • 2. Unable to access and/or navigate e-modules with reasonable support/instruction.
- • 3. Unable to speak English at a level required to understand the content of this study.
- • 4. Unable to provide informed consent.
- • 5. Less than 4 years of age.
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Edmonton, Alberta, Canada
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Marlene Dytoc, MD, PhD, FRCPC
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported